Bolli Peter
Ambulatory Internal Medicine Teaching Clinic, St. Catharines, Canada.
Am J Ther. 2008 Jul-Aug;15(4):351-5. doi: 10.1097/MJT.0b013e318164c67b.
Treatment resistant hypertension is defined as a blood pressure not achieving a goal blood pressure (<140/90 mm Hg) with a combination of three or more antihypertensive drugs. There are several causes for patients not responding to antihypertensive medication. One of the major reasons is noncompliance to the treatment, often because of real or perceived side effects or because of a great number of medications and frequent dosing. Exogenous substances, most frequently nonsteroidal anti-inflammatory drugs, and, often not recognized, over-the-counter medications containing ephedrine or pseudo-ephedrine, can reduce the effect of antihypertensive drugs. Obesity and obstructive sleep apnea oppose antihypertensive drug effects by several mechanisms but predominantly by an increase in the activity of the sympathetic and renin-angiotensin-aldosterone systems. White coat hypertension as a cause of treatment resistance is suspected if there is no target organ damage or if the patients complain of symptoms of hypotension during antihypertensive treatment. Secondary forms of hypertension, although comprising only approximately 5% of patients with treatment resistant hypertension, are important to identify because they may represent a curable form of hypertension.
联合使用三种或更多种抗高血压药物后,血压仍未达到目标血压(<140/90 mmHg)。患者对抗高血压药物无反应有多种原因。主要原因之一是不依从治疗,这通常是由于实际的或感知到的副作用,或者是由于药物种类繁多且给药频繁。外源性物质,最常见的是非甾体抗炎药,以及常常未被认识到的含有麻黄碱或伪麻黄碱的非处方药,可降低抗高血压药物的疗效。肥胖和阻塞性睡眠呼吸暂停通过多种机制对抗高血压药物的作用,但主要是通过增加交感神经和肾素-血管紧张素-醛固酮系统的活性。如果没有靶器官损害,或者患者在抗高血压治疗期间抱怨有低血压症状,则怀疑白大衣高血压是治疗抵抗的原因。继发性高血压虽然仅占难治性高血压患者的约5%,但识别它们很重要,因为它们可能是一种可治愈的高血压形式。